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The calcium (Ca) isotopic composition in urine during bed rest has been demonstrated
to be systematically light, indicating a negative bone mineral balance (i.e., bone loss).
Here we present new Ca isotope data on urine during the “nutritional countermeasures”
(NUC) bed rest study. We analyzed the Ca isotopic composition of 24 h pooled urine
samples from seven healthy male subjects during baseline data collection (BDC), head-
down-tilt bed rest and recovery. Additionally, we analyzed urine from two follow-up
examinations after the regeneration phase. We observed a change in Ca isotopic
composition during the bed rest phase, indicative of bone loss with a time delay of
10 to 21 days. We also observe that the Ca isotopic composition of urine is strongly
dependent on the individual Ca metabolism and varies between subjects. We relate this
individuality in Ca metabolism to differences in the amounts of Ca being recycled in the
kidneys. Previous studies have shown that the more Ca is reabsorbed in the kidneys
the more enriched the urine becomes in heavy isotopes of calcium. The Ca isotopic
composition of urine is thus modified by more than one process and cannot be used in a
straightforward manner to monitor net bone mineral balance. To overcome this problem,
we propose a new baseline approach for using Ca isotopes, which effectively cancels
out the effects of individual renal Ca reabsorption. This allows us to detect bone loss in
patients without ambiguity by combining measurements of the Ca isotopic composition
of urine and daily Ca excretion rate and comparing these to data collected on healthy
individuals with a normal steady-state bone balance.
Keywords: calcium isotopes, urine, renal Ca reabsorption, Ca metabolism, bone loss, bed rest
INTRODUCTION
Living under microgravity conditions in space leads to significant changes in the human body and
affects human physiology. For example, body fluids are shifted toward the upper part of the body,
and mechanical unloading of muscles and bones occurs in the lower extremities. The mechanical
unloading of bones leads to bone loss, which is a critical issue for astronauts and especially for those
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on long-duration space flights. Many of the physiological effects
of microgravity-induced changes can be simulated on Earth by a
head-down-tilt bed rest study (HDTBR) – namely, a prolonged
bed rest at a 6◦ head-down-tilt position (Rittweger et al., 2006).
This is of great interest regarding calcium (Ca) metabolism,
since HDTBR drives the net bone balance of the body out of
equilibrium.
Calcium plays an important role in many physiological
processes such as blood coagulation, synaptic transmission,
muscle contraction and cell apoptosis. In order to maintain the
functionality of physiological processes involving Ca, the Ca
concentration in blood must be held constant within small limits
(Ca homeostasis). Three organs play an important role in Ca
exchange with the environment: (1) the gastrointestinal tract
where Ca is absorbed from the diet, (2) the skeleton which is
the main reversible Ca pool in the body, and (3) the kidneys,
which regulate the excretion and recycling of calcium from blood.
The interaction of these three organs is controlled by hormones
(calcitriol, parathormone, and calcitonin) which are secreted in
response to the Ca and phosphate concentrations in blood serum
(Weaver and Heaney, 2006).
In the past few years, several studies have investigated the use
of Ca isotopes as a non-invasive tool for detecting bone loss.
During Ca transport in the body, Ca isotopes are fractionated.
This was first shown in a pioneering study by Skulan and DePaolo
(1999) who examined systematically the Ca isotopic composition
of soft and mineralized tissues in vertebrates. One important
result they found was that mineralized tissue is enriched in light
isotopes of Ca (isotopically light Ca) compared to that of blood.
During bone formation Ca in blood becomes depleted in light Ca
isotopes while, conversely, isotopically light Ca is released during
bone loss to the blood without further fractionation. Gordon
et al. (2014) successfully used the Ca isotopic composition of
blood serum to predict the active state of multiple myeloma
(MM) disease in patients. During the active state of MM, bone
is destructed and a lowering of δ44/42Cablood−serum was observed,
as predicted. The Ca isotopic composition of blood is also
transferred into urine via the kidneys, so changes in δ44/42Caurine
can also be used to monitor net bone balance in the body
(Skulan et al., 2007; Heuser and Eisenhauer, 2010; Morgan et al.,
2012). All three of these studies reported that Ca in urine is
strongly enriched in heavy Ca isotopes compared to that of
bones and blood. According to Heuser and Eisenhauer (2010)
this enrichment occurs during Ca reabsorption from primary
urine in the kidney. The light Ca isotopes are preferentially
reabsorbed from primary urine and thus lead to a relative
enrichment of heavy Ca isotopes in secondary urine. For this
reason, the use of δ44/42Caurine as marker for net bone balance
is potentially hampered by fractionation of Ca isotopes during
urine generation, which is strongly dependent on the fraction
of Ca reabsorbed in the kidneys (Heuser and Eisenhauer, 2010;
Heuser, 2016).
Here, we investigate the response of the Ca metabolism during
simulated microgravity by analyzing the Ca isotopic composition
of urine. We hypothesized that during HDTBR, Ca isotopes in
urine are sensitive for detecting even small extents of bone loss.
Additionally, the samples also allow us to gain further insight into
Ca isotope fractionation during Ca transport in the human body
under the controlled conditions of a clinical study.
MATERIALS AND METHODS
Study Details and Collection of
Biological Samples
Seven healthy, male, nonsmoking, test subjects participated in
the “nutritional countermeasures” (NUC) bed rest study. Female
subject were excluded due to a higher risk of venous trombosis
during immobilization (Bleeker et al., 2004). This study was
funded by the German Aerospace Center (Deutsches Zentrum
für Luft-und Raumfahrt, DLR) and the European Space Agency.
The subjects had mean age: 27.3 ± 3.4 years, mean body mass:
78.3 ± 6.6 kg, mean body mass index (BMI): 24.1 ± 1.9 kg/m2,
and VO2max: 39.5 ± 5.4 ml/kg body mass/min. Approval
for the study was obtained from the Ethical Committee of
the “Ärztekammer Nordrhein” in Düsseldorf, Germany, and
was conducted in accordance with the Declaration of Helsinki.
Volunteers gave their written consent after receiving detailed
information about the study protocol and the resulting risks.
An extensive medical record for each subject was taken, while a
routine medical examination and laboratory analyses were done
to exclude chronic diseases. None of the subjects received any
medication.
Subjects were confined to the bed rest facility of the DLR
Institute of Aerospace Medicine, Cologne, Germany for two
cross-over designed study campaigns, each consisting of 7 days
of pre-bed rest (BDC-7 to BDC-1), 21-days of strict six-degree
head down tilt bed rest (HDT1 to HDT21) and 6 days of post
bed rest recovery (R + 0 to R + 5; phase R1). Additional follow-
up visits took place after 14 (R + 14) and 28 days (R + 28) of
bed rest (phase R2). During the 21-day bed rest period, subjects
received potassium bicarbonate (3 × 30 mmol day−1) as a
nutritional supplement aimed at preventing an increased bed rest
induced bone resorption as the primary outcome of the study.
We focussed upon measuring Ca isotopes in the second part of
the overall HDTBR study, which involved four test subjects (B, D,
F, and H) with dietary supplementation and three without (A, C,
and G) during the bed rest period.
During the HDT period, the subjects stayed in bed 24 h a
day and all activities (including showering, eating, and weighing)
were performed in head-down-tilted-position, not allowing the
subjects to raise their heads above 30◦ from normal. During the
non-bed rest phases (adaptation and recovery), the subjects were
allowed to walk around in the ward and to do some exercise tests.
Each volunteer received an individually tailored, weight-
maintaining diet. The resting metabolic rate was computed by
resting indirect calorimetry on the first day in the ward (Deltatrac
II MBH 200 Metabolic Monitor). Energy intake was calculated
from the resting metabolic rate and an assumed physical activity
level of 1.4 for the non-bed rest phases and 1.1 for the bed
rest phases. The total energy intake was augmented by 10%
to account for diet-induced thermogenesis. Protein intake was
1.2 g/kg BM/day, 30% of calories were supplied as fat, and
the remaining energy calories were from carbohydrates. Daily
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intakes of calcium (1000–1150 mg/day), fluid (50 ml/kg BM/day),
sodium (2.8 mmol/kg BW/day) and potassium (100 mmol/day)
were also predefined and strictly controlled during the stationary
study period. Minerals and vitamins matched the minimum
value for the dietary reference intake (DRI, National Academy
of Sciences, Institute of Medicine; Food and Nutrition Board,
United States). Because subjects were not exposed to the sun, the
dietary intake of vitamin D3 was supplemented (1000 IU/day).
No caffeine, or alcohol consumption was allowed. All foods were
weighed exactly, and each volunteer was asked to consume the
complete meal.
Twenty-four-hour urine collection was done during the whole
stationary phase period. Continuous urine was collected daily on
a void-by-void basis from 7:00 (±15 min) to 7:00 (±15 min)
on the following day. Single voids were stored under darkened
and cooled conditions and subsequently pooled to 24 h volumes.
Several aliquots of the 24-h samples were stored in the freezer at
−20◦C for later analysis. Samples on day BDC-6, -2; HDT 2, 10,
21; R + 0, + 2, + 5, + 14, + 28 were processed for later analysis
for Ca isotopes. After acidifying the urine sample with 2 mol/l
HCl, the samples were aliquoted and frozen at−20◦C.
Twenty-four-hour urinary bone resorption marker
N-terminal telopeptide (UNTX) was determined with a
commercially available assay (UNTX: Osteomark R©, Wampole
Laboratories, United States) in the in-house laboratory of the
Institute of Aerospace Medicine (Cologne, Germany). Intra-
and interassay-variation were as follows: Intra: NTX 1.3%; Inter:
UNTX 4.9%.
Sample Preparation
Urine containing 25 µg of Ca was pipetted into PFA beakers
and 1 ml high-purity concentrated HNO3 and 200 µl of
H2O2 (Suprapure R©, Merck KGaA, Darmstadt) were added. This
mixture was placed on a hot plate at 120◦C for more than
12 h. After chemical digestion, a small aliquot of the solution
containing 2 µg of Ca was taken and an appropriate amount
of 43Ca-46Ca double-spike tracer solution was added (Galer,
2007). Calcium was separated from the rest of the sample
using standard cation exchange techniques utilizing quartz glass
chromatographic columns containing ∼0.7 mL of Bio-Rad AG
50W-X8 (200–400 mesh) resin and 2.0 M HCl as eluent. The
calcium fraction was dried, and a portion of about 1 µg Ca
dissolved in 5 wt.% HNO3 and loaded onto pre-degassed single or
double Re filaments. For single filaments, a Ta2O5-based activator
was loaded as well, as described in Heuser et al. (2002). Loading
onto double filaments was different: first, 1 µl of 0.01 M H3PO4
was placed onto the filament and dried down; then the sample
solution was pipetted onto the filament and dried down; finally,
the filament was raised to a current of 2.0 A for 30 s.
Mass Spectrometry and Data Reduction
Calcium isotopic compositions were measured at MPIC by
thermal ionization mass spectrometry (TIMS, Thermo Fisher
Scientific, Triton) in static multi-collection mode. All raw data
were corrected for instrumental bias using the double-spike
reduction algorithm assuming the exponential fractionation law
(Galer, 2007).
All results are reported using the common δ notation for
stable isotope variations (Eisenhauer et al., 2004; Coplen, 2011).
δ44/42Ca values (in per mil,h) were expressed according to:
δ44/42Ca =
[(44Ca/42Ca)sample / (44Ca/42Ca)reference) − 1]
× 1000 (1)
Here, the reference material used for “zero δ” is NIST SRM-
915a, in common with other studies. Samples enriched in light Ca
isotopes (isotopically “light”) compared to the reference material
have negative δ while isotopically “heavy” samples (heavy isotope
enriched) have positive δ-values. Note, that δ44/42Ca are a factor
of ∼2 smaller than δ44/40Ca values, a notation often reported
in previous work. δ44/42Ca can be converted to δ44/40Ca by
multiplying by 2.05 (see Heuser et al., 2016).
Statistics
Statistical analysis and bivariate correlations were performed
using the R programming language (The R Foundation for
Statistical Computing)1. Means and single standard errors (1SE)
are given throughout the text. P-values for correlations were
calculated using a t-test approach and are regarded as significant
when P < 0.05.
The primary aim of the study is to examine the temporal
evolution of −6◦ head-down-tilt bed rest on Ca isotopes in
urine. To evaluate trends with time we used a linear mixed effect
(LME) statistical model. The statistical tests were performed
with time as the fixed effect and the subjects as the random
effect. Time was initially coded as an ordering factor, and the
two BDC measurements from days BDC-6 and BDC-2 were
lumped together into one BDC factor level. Homoscedasticity
(homogeneity of variance) and normal distribution of residuals
were evaluated using residual plots and quantile-quantile plots.
Where significant effects of time were revealed by ANOVA, they
were further studied by a-priori contrasts of the treatment type.
Data are reported as best linear unbiased predictors (BLUP) and
standard error (SE). The level of statistical significance was set
to 0.05.
RESULTS
Anthropometric data for the seven test subjects are listed in
Table 1. Ca isotopic compositions and Ca concentrations of urine
as well as the total Ca excreted per 24 h can be found in Table 2.
δ44/42Caurine values cover a wide range from +1.2h (subject
C, HDT2) to −0.1h (subject A, HDT21) (cf. Figure 1). The
dataset shows two remarkable features: (1) huge inter-individual
differences of up to 0.8h exist in δ44/42Caurine (Figure 2) and
these differences stay nearly constant throughout the study;
(2) statistical testing (Table 2) shows that the secular variation
in δ44/42Ca is statistically significant (P < 0.001). The initial
δ44/42Ca at the start of the treatment period was 0.45± 0.12 (1SE)
at BDC; this decreased systematically by 0.15 ± 0.05 (1SE) on
1http://www.r-project.org
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TABLE 1 | Anthropometric data, δ44/42Ca (h), errors (1SE), and Ca flux (mmol/d, FCa) of the subjects from the head-down-tilt bed rest study.
Subject A B C D
Anthropometric data
Weight (kg) 79.20 71.50 88.80 74.40
Size (m) 1.85 1.82 1.78 1.79
BMI (kg/m2) 24.03 21.36 27.44 23.14
Age (yrs) 27 26 30 23
Day Phase δ44/42Ca ± FCa δ44/42Ca ± FCa δ44/42Ca ± FCa δ44/42Ca ± FCa
Ca isotope data
BDC-6 BDC 0.19 0.02 2.64 0.39 0.02 2.34 0.88 0.01 0.51 0.62 0.01 1.59
BDC-2 BDC −0.08 0.02 2.61 0.50 0.01 2.64 0.99 0.01 0.65 0.63 0.01 1.59
HDT2 HDT 0.26 0.01 3.15 1.22 0.02 0.48 0.61 0.02 1.15
HDT10 HDT 0.86 0.02 0.61 0.80 0.01 1.44
HDT21 HDT −0.12 0.02 2.49 0.33 0.02 2.18 0.82 0.01 0.82 0.63 0.02 1.69
R+0 R1 0.05 0.01 3.22 0.25 0.02 3.51 0.75 0.02 0.66 0.72 0.02 1.40
R+2 R1 0.32 0.02 2.61 0.20 0.02 2.93 0.77 0.02 1.00 0.60 0.02 2.25
R+5 R1 −0.06 0.01 2.62 0.15 0.01 2.82 0.89 0.01 0.67 0.65 0.01 1.46
R+14 R2 0.31 0.02 4.81 0.37 0.02 1.72 1.17 0.02 0.82 0.75 0.01 1.56
R+28 R2 0.24 0.01 6.21 0.51 0.01 3.52 0.90 0.01 1.46 0.66 0.02 2.35
Subject F G H
Anthropometric data
Weight (kg) 85.50 80.50 72.20
Size (m) 1.86 1.79 1.76
BMI (kg/m2) 24.61 24.49 23.33
Age (yrs) 33 26 30
Day Phase δ44/42Ca ± FCa δ44/42Ca ± FCa δ44/42Ca ± FCa
Ca isotope data
BDC-6 BDC 0.53 0.02 1.83 0.26 0.01 1.73 0.24 0.01 2.91
BDC-2 BDC 0.43 0.01 1.73 0.42 0.01 1.39 0.29 0.01 2.65
HDT2 HDT 0.54 0.01 1.28 0.31 0.01 1.53 0.29 0.01 2.57
HDT10 HDT 0.48 0.01 1.63 0.27 0.01 2.04 0.15 0.01 3.49
HDT21 HDT 0.31 0.01 1.50 0.00 0.01 2.29 0.11 0.01 3.09
R+0 R1 0.46 0.02 2.19 0.08 0.01 2.01 0.08 0.01 4.83
R+2 R1 0.32 0.01 1.64 0.12 0.01 2.16 0.04 0.01 4.79
R+5 R1 0.30 0.01 1.68 0.07 0.01 1.62 −0.06 0.01 3.87
R+14 R2 0.41 0.01 2.05 0.16 0.01 3.42 0.16 0.01 3.85
R+28 R2 0.78 0.02 1.32 0.18 0.01 3.18 0.29 0.01 1.63
HDT21 (P = 0.004), by 0.11 ± 0.05 (1SE) on R + 0 (P = 0.034),
by 0.1711 ± 0.05 (1SE) on R + 2 (P = 0.031), and by 0.17 ± 0.05
on day R + 5 (P = 0.0011). Notably, no statistically significant
change was observed on day HDT2 (P = 0.14) or on day HDT10
(P = 0.90).
DISCUSSION
Individuality of Ca Metabolism
Boxplots of the δ44/42Caurine for each of the subjects A to H
(Figure 1) show that the urinary Ca isotopic compositions during
pre-bed rest BDC span a wide range and are different for most of
the subjects. The maximum difference of about 0.8h is observed
between subjects A and C. Such huge inter-individual Ca isotope
differences have been observed previously for urine and blood
samples from other bed rest studies (Skulan et al., 2007; Morgan
et al., 2012; Channon et al., 2015) as well as in archeological
bones (Reynard et al., 2010). Figure 2 shows a comparison
of the observed inter-individual ranges in δ44/42Caurine and
δ44/42Cablood. The span of δ44/42Caurine in our dataset is the same
order of magnitude as that already reported in the literature
(Skulan et al., 2007; Morgan et al., 2012).
In their pilot study, Heuser and Eisenhauer (2010) analyzed
δ44/40Caurine of a 63-year-old woman suffering from osteoporosis
and a 4-year-old healthy boy. A difference of 1.1h in δ44/40Ca
(0.55h in δ44/42Ca) was observed between their average urinary
Ca isotopic compositions. This offset was attributed to differences
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TABLE 2 | Best linear unbiased predictors (and their standard errors) as obtained
from the linear mixed effect model, and the P-levels for the a priori contrasts.
Day δ44/42Ca 1SE P
BDC 0.45 0.12 <0.001
HDT02 0.08 0.05 0.1407
HDT10 −0.01 0.06 0.9034
HDT21 −0.15 0.05 0.0037
R+0 −0.11 0.05 0.0344
R+02 −0.11 0.05 0.0307
R+05 −0.17 0.05 0.0011
R+14 0.03 0.05 0.5769
R+28 0.06 0.05 0.2551
Significant time effects have been set in bold face.
in the net bone balance of the two subjects. While the woman
had a negative bone balance (loss > gain) the opposite was true
for the boy. It can be assumed that the subjects A to H of this
bed rest study are not very different in their pre-bed rest net
bone balance. Thus, it is unlikely that net bone balance could
be the main cause of the inter-individual differences in δ44/42Ca
observed in Figure 1.
The principal finding of this study is that δ44/42Ca is
systematically lowered during bed rest. However, this lowering is
occurring with a time delay of 10 to 21 days. After re-ambulation,
δ44/42Ca returns back to baseline values again, after a time
delay of 6 to 14 days. Similar time delays have been observed
for biochemical markers of bone resorption at the onset and
termination of bed rest (Armbrecht et al., 2010) Furthermore,
bone mineral content of the tibia decreases for another 10 to
20 days after re-ambulation following bed rest (Rittweger et al.,
2010) and after unilateral limb suspension (Rittweger et al.,
2006).
Based upon the Ca isotope dataset of our study, we can
establish that time delays in the bone’s response to disuse
and re-ambulation are present on the levels of: (1) the
organic matrix turn-over, (2) calcium trafficking between body
fluids and bone, and (3) the anatomical bone structure. As
hypothesized by Rittweger et al. (2016), we propose that
differentiation and migration of osteoclast precursors and of
osteoblasts provide the most likely explanation for the time
delays observed. If so, this would imply that determination
of bone precursor cells may be a more potent driver of
bone’s mechanical adaptation than modulation of existing bone
cells.
One also needs to consider that differences in dietary
Ca isotopic composition (δ44/42Cadiet) could be the origin
of the observed differences in the δ44/42Caurine. But
since all test persons received a similar diet, inter-subject
differences caused by δ44/42Cadiet should decrease during
the course of our study. However, this is not observed
(cf. Table 1); rather, the inter-individual differences stay
nearly constant during the whole study period. In addition,
it has been shown that the Ca isotopic composition of a
diet that is dominated by dairy products (Chu et al., 2006;
Heuser and Eisenhauer, 2010; Heuser, 2016) does not
FIGURE 1 | Boxplots of δ44/42Caurine values for each phase for the seven
subjects A to H. Stars indicate subjects with KHCO3 supplementation.
Phases are: BDC: pre-bed rest baseline data collection (BDC-6 and BDC-2),
HDT: head down tilt bed rest (HDT2, HDT10, and HDT21), R1: post bed rest
recovery (R + 0, R + 2, and R + 5) and R2: outpatient regeneration (follow-up
examination; R + 14 and R + 28).
vary as much as the 0.8h range observed in our study.
In summary, δ44/42Cadiet probably accounts for only a
minor portion of the observed inter-individual differences
of δ44/42Caurine.
The observed differences in average pre-bed rest δ44/42Caurine
are also not correlated to age (r2 = 0.11, P = 0.858),
weight (r2 = 0.21, P = 0.295), body height (r2 = 0.11,
P = 0.467) or the BMI (r2 = 0.26, P = 0.239) of the subjects
(Figure 3).
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FIGURE 2 | Boxplots of Ca isotopes showing pre-bed rest data (BDC) for all
subjects combined from this study (n = 7), along with the studies of Skulan
et al. (2007) (n = 9), Morgan et al. (2012) (n = 12), and Channon et al. (2015)
(n = 12). Data from Channon et al. (2015) and Morgan et al. (2012) were
obtained from identical subjects in the same bed rest study. Open circles
represent statistical outliers. The span (max–min) in the δ44/42Caurine values is
higher than the observed span in δ44/42Cablood values. The data from Skulan
et al. (2007) have been recalculated from the original δ44/40Ca values. All
literature data have been converted to conform to NIST SRM-915a reference
material (see Section 3.2).
It is possible to calculate δ44/42Caurine using a Rayleigh-type
fractionation model (Heuser and Eisenhauer, 2010):
δ44/42Caurine = (δ44/42Cablood + 1000) · fexcreted (α−1) − 1000
1000 (2)
where α is the fractionation factor between primary and
secondary urine, δ44/42Cablood is the input Ca isotopic
composition of the blood and f excreted is the percentage of
Ca not reabsorbed in the kidneys, that is collected in the bladder
and then excreted. The fractionation factor α is a measure for
the amount of isotopic fractionation in an exchange reaction.
Assuming the same fractionation factor α between subjects
it can be seen from Equation (2) that differences in f excreted
between subjects have a major influence on δ44/42Caurine and
should also be reflected in the amount of Ca excreted via urine.
In particular, the more Ca that is reabsorbed from primary
urine, the less total Ca that will be excreted, and the higher
the δ44/42Caurine becomes. This can be tested since differences
in the fraction of Ca being reabsorbed in the kidneys between
subjects should be reflected in the amount of Ca excreted via the
urine.
Indeed, a significant correlation (r2 = 0.93, P < 0.001) does
exist between δ44/42Caurine and total excreted Ca (mmol/24 h),
as can be seen in Figure 4. This correlation suggests that
variable individual renal Ca reabsorption is the main cause of the
observed inter-individual differences in δ44/42Caurine.
Furthermore, the amount of renal Ca reabsorption is not
directly linked to dietary Ca input. The dietary Ca intake between
all test persons varied by a factor of 1.2, being only slightly lower
than the amounts of individual excreted Ca (factors of 1.3 to 2.3).
The differences in the excreted urinary Ca between the subjects
varied by, on average, a factor of 4.3 ± 1.3 (1SD). This pattern
of higher differences between subjects compared to differences
over the course of study for an individual can also be observed
in the δ44/42Caurine dataset, which shows smaller intra-individual
variation than inter-individual differences.
A change in the fractionation factor during renal Ca
reabsorption cannot be excluded. Such a fractionation factor
change might plausibly be linked to the amount of cells being
involved during transcellular and paracellular transport of Ca in
the kidneys, which is ultimately controlled by different hormones
(e.g., Mundy and Guise, 1999; Hoenderop et al., 2005; Peacock,
2010). Such a scenario might also change the fraction of Ca
reabsorbed, with both effects combining and amplifying the net
extent of Ca isotope fractionation in the urine.
Response of δ44/42Caurine to Bed Rest
In general, δ44/42Caurine decreases during the bed rest phase
(Figure 5). This change in δ44/42Caurine is fully in accord with
isotopically “light” Ca being released from bones during bone
resorption and, indeed, the changes during bed rest in our study
match those reported in the literature (Skulan et al., 2007; Morgan
et al., 2012; Channon et al., 2015; see Figure 6). We found
a change, on average, of about −0.15h over the time of bed
rest, while Skulan et al. (2007) reported a change of −0.48h
(control group, 17 weeks of bed rest) and, similarly, Morgan
et al. (2012) found −0.2h (4 weeks of bed rest). The differences
in δ44/42Caurine shifts during bed rest periods observed between
studies can most likely be attributed to the different length of the
bed rest phase in each case.
Our Ca isotope dataset shows a small difference between the
group of subjects with and without supplement of potassium
bicarbonate (KHCO3), although this is statistically not significant
(Figure 6). Specifically, the mean change of δ44/42Caurine from
baseline is −0.21h for subjects without KHCO3 supplement,
while it is−0.11h for those who took the supplement.
Up to now, changes in δ44/42Caurine have been interpreted
to be the consequence of bone resorption only. Support for
this explanation comes from (1) the data of Channon et al.
(2015) who, like in the present study, found a decrease in
δ44/42Cablood during bed rest, and (2) from Skulan et al. (2007)
who reported a correlation between δ44/42Caurine and changes
in conventional serum biomarkers for bone resorption. Other
physiological effects during bed rest that might lead to changes
in δ44/42Caurine have not yet been fully investigated, however.
For example, assuming a constant amount of Ca transported
from the intestine into blood along with prolonged bone
resorption during bed rest, the Ca concentration in blood must
increase and will be regulated by an increase in overall Ca
excretion. But, in order to increase Ca excretion, the fraction
of Ca that is reabsorbed in the kidneys (f ) must decrease. In
terms of Ca fractionation this will result in lower δ44/42Caurine
as increased amounts of Ca are being excreted (cf. Figure 4).
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FIGURE 3 | Average δ44/42Caurine during the pre-bed rest phase (BDC-6 and BDC-2) plotted against age (A), size (B), weight (C), and body mass index (BMI) (D) of
the subjects. This illustrates that there are no statistically significant correlations between δ44/42Caurine and any of the anthropometric parameters.
A decrease in the fraction of Ca being reabsorbed from 98 to
97% would cause a lowering of δ44/42Caurine by about −0.1h.
Thus, the shift in δ44/42Caurine during the bed rest phase can be
explained by either the addition of isotopically “light” Ca from
bones to the blood or, alternatively, by a change in the renal Ca
excretion factor (f) or, more probably, the combined effect of
both.
The observed inter-individual differences in δ44/42Caurine
and corresponding δ44/42Cablood from the studies of Morgan
et al. (2012) and Channon et al. (2015), respectively, support
a changing excretion factor (f ) during bed rest. While
the inter-individual differences (max δ44/42Ca–min δ44/42Ca)
are about 0.85h for δ44/42Caurine at the end of the bed
rest phase, the reported shift in δ44/42Cablood is smaller
(0.46h).
On the other hand, an increase in the concentration of free
Ca in the blood triggers a serum parathyroid hormone (PTH)
concentration decrease (Mundy and Guise, 1999). Consequently,
the decrease of PTH concentration then results in a decrease in
intestinal Ca absorption and a lowered renal Ca reabsorption
(Mundy and Guise, 1999).
Comparison of δ44/42Caurine With NTX
Serum NTX (n-telopeptide cross-links) is a frequently used
biochemical marker for bone resorption (e.g., Iba et al., 2008).
Skulan et al. (2007) reported changes in NTX alongside
δ44/42Caurine in their samples. At first glance their data suggests
a correlation between NTX and δ44/42Caurine since mean
δ44/42Caurine decreases during bed rest as mean NTX increases.
This qualitative correlation suggests that changes in δ44/42Caurine
during bed rest are linked to increased bone resorption. Such
a qualitative correlation between δ44/42Caurine and changes in
NTX is also seen in our dataset. Relative to pre-bed rest values,
the mean change in δ44/42Caurine post-bed rest is −0.10h while
the corresponding change in NTX is 393 (nmol/d). But a closer
look at the pooled data shows that there is in fact no statistically
significant correlation between δ44/42Caurine and NTX (Figure 7;
P > 0.99), nor for any of the subjects individually (cf. Table 2).
A Promising New Baseline Approach
Based on our data and those from previous studies, bone loss
cannot be detected unambiguously using δ44/42Caurine if the
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FIGURE 4 | Mean δ44/42Caurine (±1SD) of the BDC (BDC-6 and BDC-2)
phase of each subject plotted against the average excreted Ca per 24 h
(±1SD). A significant logarithmic correlation exists that is statistically
significant (r2 = 0.884, P < 0.001; white dashed line). Such a correlation is
typical for Rayleigh-type fractionation such as might be expected during
generation of secondary urine in the kidneys. These data were collected
before and after the head-down-tilt bed rest period. The gray shaded area
represents the 95% confidence band of the logarithmic regression trend.
FIGURE 5 | Average changes in δ44/42Ca from baseline values for all subjects
as a function of day during our bed rest study. The baseline value is
represented by the average δ44/42Ca of all subjects during the BDC period
(BDC-6 and BDC-2). The phases of the study are: BDC: pre-bed rest baseline
data collection, HDT: head-down-tilt bed rest, R1: inpatient regeneration and
R2: outpatient regeneration (follow-up examinations).
(steady state) pre-bone-loss baseline δ44/42Caurine of the patient
is unknown. This hampers the easy application of δ44/42Caurine
as a diagnostic tool for detecting disease related to bone loss,
FIGURE 6 | Boxplot of changes in urinary Ca isotopic composition obtained
during our study. For comparison, the data of Skulan et al. (2007); Morgan
et al. (2012), and Channon et al. (2015) are also shown. Overall, the changes
observed in the study are in good agreement with those found in previous
studies. A small but statistically insignificant difference between the control
group (C) and the KHCO3 supplemented group (S) can be seen. Letters for
the Skulan et al. dataset correspond to: (C) control group, (E) exercise group,
and (A) alendronate supplemented group.
FIGURE 7 | Plot of changes in Ca isotopic composition versus those in NTX
excretion, both from relative to baseline at the end of the bed rest phase
(HDT21). Qualitatively, both biomarkers show bone loss but there is no strong
correlation evident between them.
such as osteoporosis. Here, the main problem seem to be in the
unknown amount of Ca being reabsorbed in the kidneys for each
patient. But on the other hand, using δ44/42Caurine it should still
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FIGURE 8 | Log-log plot of 44Ca/42Ca in urine versus daily-excreted Ca
(mmol/d) for the pre-bed rest BDC data (BDC-6 and BDC-2, yellow squares)
and directly after the bed rest phase (R + 0, R + 2, and R + 5, green
diamonds). Both sets of data show negative correlations with trend lines
indicated (BDC, gray; R + 0, black dashed), with the after bed rest data
shifted systematically toward lower 44Ca/42Ca, i.e., more negative δ44/42Ca.
This vertical offset likely reflects bone loss during bed rest independent of
changes arising from variable renal Ca reabsorption in the kidneys.
be possible to monitor the success of an on-going osteoporosis
therapy aimed at reducing bone resorption.
In order to overcome this problem we propose a new baseline
approach intended to reduce the unknown renal Ca absorption
effect on δ44/42Caurine. In a log-log plot of 44Ca/42Caurine versus
the amount of excreted Ca per day (Figure 8) two different
negatively sloped trends can be seen, for the adaption (BDC) and
bed rest (R + 0, R + 2, R + 5) phase. The BDC samples follow a
linear trend (r2 = 0.780, P < 0.001) with a slope of−5.38× 10−4
and a y-axis intercept of 1.177, while the bed rest samples linear
trend (r2 = 0.790, P < 0.001) has a slope of −5.43 × 10−4 and
y-axis intercept of 1.176. Although both trends are not strictly
parallel to one another, they remain basically parallel within the
range of excreted Ca measured. The offset between the two trends
seen in Figure 8 indicates that the Ca isotopic composition for
any given Ca excretion rate is always isotopically “lighter” at the
end of the bed rest relative to the BDC baseline.
Thus, we suggest that a combined measurement of daily
Ca excretion rate as well as δ44/42Caurine may be sufficient to
implicate patient bone resorption, if the data lie below the BDC
trend when plotted in Figure 8. For the time being, this inference
must be considered tentative, pending better definition of the
BDC line in Figure 8 from future studies; this can be done
relatively easily, however, since it just involves measurement of
these two parameters in healthy individuals whose Ca balance is
at steady state.
We used the R1 data here, as they should be the most affected
by the bed rest phase. Based on Figure 6 it seems justified to
assume that the shift from the baseline trend would be even
more pronounced during longer periods of bed rest. Figure 6
also shows a small but not significant difference between the
control group (C) and the supplemented group (S). While the
control group defines a linear trend shifted parallel toward lower
δ44/42Ca, the supplemented group defines a trend with a lower
slope and higher y-axis intercept. Currently, we do not have a
good explanation for this – it might be related to the supplement
of KHCO3 but may also be simply a statistical artifact due to the
limited number of subjects in each group (nC = 3, nS = 4).
One should keep in mind that the data currently available, here
and elsewhere, are far too few in number to define a statistically
meaningful BDC δ44/42Caurine versus excreted Ca rate baseline.
Nevertheless, it does reveal a promising way for canceling out
the patient-specific effects of renal Ca reabsorption on measured
δ44/42Caurine. In order to assess whether such a common BDC
baseline approach actually works, many more data will be needed.
Furthermore, the influence of dietary Ca isotopic composition
on δ44/42Caurine and other potential fractionation mechanisms in
the body have to be better understood, and represent significant
gaps in our present knowledge that must be addressed in future
studies.
SUMMARY AND CONCLUSION
We present time series of Ca isotopic compositions in urine from
seven individuals participating in a 21-day bed rest study. Our
results document systematic temporal variations in the isotopic
composition of excreted calcium. As bed rest progresses, the Ca
isotopic composition of urine is shifted toward “lighter” values
compared to pre-bed rest compositions. This can be explained by
an increased flux of isotopically light Ca entering the blood from
bone dissolution, and thus these shifts may be a useful indicator
of bone loss. Statistical analyses of the data show a time delay of
14 to 21 days before the shifts in urine Ca isotopic composition
become apparent. This finding is consistent with time delays
observed in biochemical markers of bone’s organic matrix, as well
as in bone densitometric measurements.
The data show huge differences in δ44/42Caurine between
individuals of up to 0.8h. These differences are most likely
caused by each subject’s unique Ca metabolism, and especially
the percentage of Ca being reabsorbed in the kidneys. Small
differences in the renal Ca reabsorption rate can easily explain the
magnitude of the observed inter-individual δ44/42Caurine shifts.
The fact that the amounts of Ca excreted daily are well correlated
with δ44/42Caurine implicates renal Ca reabsorption rate as the
cause of these differences.
The individuality in Ca metabolism hampers the use of
δ44/42Caurine in a straightforward manner for determining net
bone mineral balance or detecting disorders in Ca metabolism.
This problem can be overcome if a δ44/42Caurine baseline can be
determined for the individual prior to bone loss. Then, changes in
δ44/42Caurine from the baseline can be directly related to the net
bone mineral balance and/or Ca metabolism.
An extremely important finding is that the data on all seven
subjects, taken together, show a strong correlation between
the total amount of excreted Ca and Ca isotopic composition
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of urine. We observe that δ44/42Caurine is lower during the
bed rest phase compared to pre-bed rest phase δ44/42Caurine
for an identical amount of excreted Ca. This suggests that it
may be possible to use data on δ44/42Caurine and amounts of
urinary Ca excreted from healthy persons to construct a normal
bone balance baseline for the general population. In this case,
offsets from the baseline would be diagnostic of disorders in Ca
metabolism; in particular, individuals with net bone loss would
be expected to exhibit lower δ44/42Caurine for a given amount of
excreted Ca relative to the baseline.
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